SCHEMBL12578602

SCHEMBL12578602

CCC(C)(CC(C)c1ccc(O)cc1)C(=O)OC(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 8/20 0.39
ESR2 Q92731 6/20 0.39
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
PGR P06401 1/20 0.35
CHRM2 P08172 1/20 0.35
CYP3A4 P08684 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
AR P10275 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPT P10636 1/20 0.35
CHRM1 P11229 1/20 0.35
CYP2C9 P11712 1/20 0.35
ALOX15 P16050 1/20 0.35
DRD1 P21728 1/20 0.35
TBXA2R P21731 1/20 0.35
PTGS1 P23219 1/20 0.35
SLC6A2 P23975 1/20 0.35
CYP2C19 P33261 1/20 0.35
ADRA1A P35348 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15613863 0.88 ESR1 (0.41) ESR1ESR2LMNACYP1A2PGR
SCHEMBL17721325 0.87 RIPK1 (0.42) CYP1A2CYP2D6MAPTCYP2C19CTSS
SCHEMBL18347556 0.86 ESR1 (0.41) ESR1ESR2LMNACYP1A2PGR
SCHEMBL19420336 0.84 ESR1 (0.38) ESR1ESR2LMNACYP1A2PGR
SCHEMBL15979584 0.84 ESR1 (0.40) ESR1ESR2LMNACHRM2CYP3A4
SCHEMBL26374247 0.84 ESR1 (0.35) ESR1LMNAMAPTOPRM1CTSK
SCHEMBL18347549 0.83 ESR1 (0.44) ESR1ESR2LMNACYP1A2PGR
SCHEMBL26374273 0.83 LMNA (0.36) ESR1ESR2LMNACHRM2
SCHEMBL19679943 0.83 ESR1 (0.35) ESR1ESR2MAPTMIFPDCD1
SCHEMBL2736409 0.81 CYP2C9 (0.35) ESR1ESR2LMNACYP1A2PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9217919-B2 Photosensitive composition, pattern-forming method using the composition, and resin used in the composition FUJIFILM CORPORATION (JP) 2015-12-22 US disclosed
US-20140242520-A1 I-LINE PHOTORESIST COMPOSITION AND METHOD FOR FORMING FINE PATTERN USING SAME DONGJIN SEMICHEM CO., LTD. (KR) 2014-08-28 US disclosed
US-20110159433-A1 PHOTOSENSITIVE COMPOSITION, PATTERN-FORMING METHOD USING THE COMPOSITION, AND RESIN USED IN THE COMPOSITION FUJIFILM CORPORATION (JP) 2011-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110159433-A1 PHOTOSENSITIVE COMPOSITION, PATTERN-FORMING METHOD USING THE COMPOSITION, AND RESIN USED IN THE COMPOSITION SUN2, LCP1, PHYKPL ESR1 1396/4885ESR2 1722/4885LMNA 1348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.